NanoString Technologies, Inc. NSTG

Full chart Compare
Set alert

Price alert · NSTG

All alert types
0.11 0.00 (+0.00%)

At closeJun 17, 2025, 4:00 PM EDT

0.1025 Day range 0.13999

52-week range unavailable

Market cap
5.07M
Revenue (ttm)
162.47M
Profit margin
-102.44%
Shares out
48.12M
Forward P/E
-0.06
Volume
21.43M
Open
0.128
Previous close
0.1053
Day's range
0.1025 – 0.13999
Beta
1.24
Analysts
Buy
Price target
0.25 (+137.4%)
Earnings date
Feb 27, 2024

 

No chart data for this range yet.

Key statistics

Enterprise value
154.02M
PEG ratio
0.00
Price / sales
0.03
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
62.80%
Free cash flow
-81.48M
Total cash
97.10M
Total debt
247.70M
Return on equity
-1028.56%
Short % of float
16.67%
50-day average
0.403199
200-day average
2.15

Financials — quick view

All financials
NSTG Revenue — quarterly 48.09M
2019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-312023-06-302023-09-30
NSTG Net income — quarterly -37.41M
2019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-312023-06-302023-09-30
NSTG EPS — quarterly -0.78
2019-12-312020-03-312020-06-302020-09-302020-12-312021-03-312021-06-302021-09-302021-12-312022-03-312022-06-302022-09-302022-12-312023-03-312023-06-302023-09-30

Earnings

NSTG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 27, 2024Dec 1, 2023-0.47———
Nov 6, 2023Sep 1, 2023-0.53———
Aug 3, 2023Jun 1, 2023-0.70———
May 3, 2023Mar 1, 2023-0.72———
Feb 28, 2023Dec 1, 2022-0.61———
Nov 7, 2022Sep 1, 2022-0.46———

About NanoString Technologies, Inc.

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on NSTG — it syncs with the Stock Master app.

Insider holders

NSTG insider holders
InsiderRelationLatest transactionDateShares held
BEECHEM JOSEPH MOfficerStock Award(Grant)Aug 31, 202395,017
FINNEY ELISHA WDirectorConversion of Exercise of derivative securityJun 15, 202321,446
FOY TERESA M.DirectorConversion of Exercise of derivative securityJun 15, 20236,275
GEORGE JANETDirectorConversion of Exercise of derivative securityJun 15, 202319,268
GRAY ROBERT BRADLEYChief Executive OfficerStock Award(Grant)Aug 31, 2023338,682
MALLOY KIRKDirectorConversion of Exercise of derivative securityJun 15, 202324,251

Institution ownership

NSTG institution ownership
Holder% heldSharesValueReported
Polar Capital Holdings PLC8.26%3,975,000418.57KDec 30, 2023
Blackrock Inc.7.43%3,574,938376.44KDec 30, 2023
Vanguard Group Inc7.42%3,569,859375.91KSep 29, 2023
Platinum Investment Management Ltd5.77%2,775,853292.30KDec 30, 2023
Morgan Stanley4.85%2,333,231245.69KDec 30, 2023
Avidity Partners Management, LP4.78%2,299,100242.09KSep 29, 2023

Fund ownership

NSTG fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.93%1,409,732148.44KSep 29, 2023
iShares Russell 2000 ETF2.74%1,319,049138.90KDec 30, 2023
Vanguard Extended Market Index Fund1.41%679,55171.56KSep 29, 2023
Vanguard Horizon Fund-Strategic Small-Cap Equity Fund1.09%522,90155.06KSep 29, 2023
Fidelity Small Cap Index Fund0.95%457,67848.19KNov 29, 2023
iShares Russell 2000 Growth ETF0.80%384,59640.50KDec 30, 2023